Over the past several years, many states, including Colorado, have approved medical marijuana legislation. There is concern that increased access to and visibility of medical marijuana may lead to harmful use.
Methods
This study examined changes in patients’ marijuana use in 12 health care settings through a statewide screening, brief intervention, and referral to treatment (SBIRT) initiative.
Results
Beginning in 2009, the odds of screening positive for risk-prone marijuana use significantly increased, coinciding with dramatic increases in use of Colorado's medical marijuana program. Young males were most likely to screen positive. Among users, there was a small, statistically significant increase in severity of use over time.
Conclusions
Findings suggest that health care providers may be serving increasing numbers of patients using marijuana for medical or recreational perposes.
Substance Abuse and Mental Health Services Administration (SAMHSA). 2011. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658, Rockville, MD, Office of Applied Studies
2.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 2009. “Treatment Episode Data Set (TEDS): 1996–2006”. In National Admissions to Substance Abuse Treatment Services, Rockville, MD: Substance Abuse and Mental Health Services Administration. Available at: http://oas.samhsa.gov/TEDS2k7highlights/TEDSHighl2k7Tbl2b.htm. Accessed January 5, 2012
3.
National Institute on Drug Abuse. 2002. NIDA Research Report Series: Marijuana Abuse, Bethesda, MD: National Institutes of Health. Revised 2010. Available at: http://www.nida.nih.gov/ResearchReports/Marijuana/default.html. Accessed February 26, 2012
4.
CerdaM, WallMKeyesK. 2012. Medical marijuana laws in 50 states: investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug Alcohol Depend., 120: 22–27.
StoneA, BeckerLHuberA. 2012. Review of risk and protective factors of substance use and problem use in emerging adulthood. Addict Behav., 37: 747–775. doi:10.1016/j.addbeh.2012.02.014
8.
JoffeA and YancyS. 2004. Legalization of marijuana: potential impact on youth. Pediatrics., 113: 632–638.
9.
ThurstonC. Medical marijuana. Presentation given at Denver Epidemiology Work Group, Denver, COOctober
10.
HumeniukR E, Henry-EdwardsS, AliR L, PoznyakV and MonteiroM. 2010. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for Use in Primary Care, Geneva: World Health Organization.
11.
HumeniukR E, AliR ABaborT F. 2008. Validation of the Alcohol Smoking and Substance Involvement Screening Test (ASSIST). Addiction., 103: 1039–1047.
12.
World Health Organization ASSIST Working Group. 2002. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction., 97: 1183–1194.
13.
SherrerJ, GrantJDuncanA. 2008. Measured environmental contributions to cannabis abuse/dependence in an offspring of twins design. Addict Behav., 33: 1255–1266.
14.
von SydowK, LiebRPfisterH. 2002. What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend., 68: 49–64.
15.
WindleM and WiesnerM. 2004. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Dev Psychopathol., 16: 1007–1027.
16.
AgrawalA and LynskeyM. 2006. The genetic epidemiology of cannabis use, abuse and dependence. Addiction., 101: 801–812.
17.
WangT, ColletJ, ShapiroS and WareM. 2008. Adverse effects of medical cannabinoids: a systematic review. CMAJ., 178: 1669–1678.
18.
AbramsD, HiltonJLeiserR. 2003. Short-term effects of cannabinoids in patients with HIV-1 Infection. Ann Intern Med., 139: 258–266.
19.
HallW. 2009. The adverse health effects of cannabis use: what are they, and what are their implications for policy?. Int J Drug Policy., 20: 458–466.
20.
LeungL. 2011. Cannabis and its derivatives: review of medical use. J Am Board Fam Med., 24: 452–462.
21.
PolenM, SidneySTekawaI. 1993. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med., 158: 596–601.
22.
MooreB, AugustonEMoserR. 2005. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med., 20: 33–37.
23.
GrotenhermenF. 2007. The toxicology of cannabis and cannabis prohibition. Chem Biodivers., 4: 1744–1769.
24.
AshtonC H. 2001. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry., 178: 101–106.
25.
ReeceA S. 2009. Chronic toxicology of cannabis. Clin Toxicol., 47: 517–524.
26.
LindseyW, StewartD and ChildressD. 2012. Drug interactions between common illicit drugs and prescription therapies. Am J Drug Alcohol Abuse, 38: 334–343. doi:10.3109/00952990.2011.643997
27.
GerberichS, SidneySBraunB. 2003. Marijuana use and injury events resulting in hospitalization. Ann Epidemiol, 13: 230–237.
28.
LiM C, BradyJDiMaggioC. 2012. Marijuana use and motor vehicle crashes. Epidemiol Rev, 34: 65–72. doi:10.1093/epirev/mxr017
29.
MadrasB, ComptonWAvulaD. 2009. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparisons at intake and 6 months later. Drug Alcohol Depend., 99: 280–295.
30.
StephensR, RoffmanR and CurtinL. 2000. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol., 68: 898–908.
31.
Marijuana Treatment Project Research Group. 2004. Brief treatments for cannbis dependence: findings from a randomized multisite trial. J Consult Clin Psychol., 72: 455–466.
32.
World Health Organization. 2008. The Effectiveness of a Brief Intervention for Illicit Drugs Linked to the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) in Primary Health Care Settings: A Technical Report of Phase III Findings of the WHO ASSIST Randomized Controlled Trial, Geneva: World Health Organization. Available at: http://www.who.int/substance_abuse/activities/assist_technicalreport_phase3_final.pdf. Accessed May 30, 2012
33.
SaitzR, AlfordDBernsteinJ. 2010. Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J Addict Med., 4: 123–130.
